Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Grant or award Director acquired 14,775 shares (grant or award)
  2. 4 Grant or award Director acquired 14,775 shares (grant or award)
  3. 4 Grant or award Director acquired 14,775 shares (grant or award)
  4. 4 Grant or award Director acquired 14,775 shares (grant or award)
  5. 4 Grant or award Director acquired 14,775 shares (grant or award)
  6. 4 Grant or award Director acquired 14,775 shares (grant or award)
  7. 4 Grant or award Director acquired 14,775 shares (grant or award)
  8. 4 Open-market sale Principal Accounting Officer sold 3,529 shares at an average $8.57 ($30,246)
  9. 4 Open-market sale Chief People Officer sold 6,816 shares at $8.57 ($58,413)
  10. 4 Open-market sale SVP and General Counsel sold 18,878 shares at an average $8.59 ($162,186)
  11. 4 Open-market sale Chief Operating Officer sold 23,684 shares at an average $8.59 ($203,487)
  12. 4 Grant or award Chief Financial Officer acquired 118,203 shares (grant or award)
  13. 4 Open-market sale Chief Commercial Ofc Imm Med sold 11,749 shares at $8.57 ($100,689)
  14. 4 Open-market sale Chief Commercial Officer, MRD sold 16,474 shares at an average $8.59 ($141,477)
  15. 4 Open-market sale President sold 22,668 shares at $8.57 ($194,265)
  16. 4 Grant or award Chief Scientific Officer acquired 354,610 shares (grant or award)
  17. 4 Grant or award CEO and Chairman acquired 354,610 shares (grant or award)
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 17 of 42 · 837 filings